At Vision BioSciences, we are a biotechnology company committed to developing regenerative therapeutics for geographic atrophy and other retinal degenerative diseases. Founded and led by a highly accomplished retina and vitreous surgeon with extensive experience as a primary investigator in hundreds of clinical research trials, Vision BioSciences combines deep clinical expertise with innovative science to advance the future of regenerative vision care.
Our work focuses on leveraging cell and gene therapy to create novel approaches that have the potential to restore and preserve sight. Guided by our mission to restore vision through regenerative therapeutics, we bring together a team of experts in ophthalmology, biotechnology, and clinical research, united by a shared commitment to improving patient outcomes and transforming the treatment landscape for vision loss.
At Vision BioSciences, we believe restoring vision means more than improving sight, it means restoring independence, connection, and quality of life.
